Intuitive Surgical, Inc.
Intuitive Surgical to Acquire da Vinci Distribution in Southern Europe
Summary
Intuitive Surgical, Inc. announced on January 21, 2025, that it has entered into a definitive agreement to acquire the da Vinci and Ion distribution businesses from its current distributors in Italy, Spain, Portugal, Malta, and San Marino. The transaction, expected to close in the first half of 2026, comprises an upfront cash payment of approximately €290 million and up to an additional €31 million in commercial milestone cash payments. Separately, on January 23, 2025, Intuitive reported financial results for the quarter and full year ended December 31, 2024. Q4 2024 revenue was $2.41 billion, up 25% year-over-year, and full-year 2024 revenue reached $8.35 billion. Non-GAAP net income for Q4 2024 was $805 million, and for the full year, it was $2.66 billion.
Profitelligence Alerts
Get alerts for ISRG
Be first to know when Intuitive Surgical, Inc. files with the SEC.
Filing Categories
Exhibits (2)
Advertisement
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is a pioneering company in the field of robotic-assisted, minimally invasive surgery. It is renowned for its development of the da Vinci Surgical System, which revolutionizes surgical procedures by enhancing precision, flexibility, and control beyond the physical capabilities of the human hand. The company's cornerstone product allows surgeons to perform complex surgeries through small incisions, which can lead to quicker patient recovery, reduced hospital stays, and lower complication rates. Operating predominantly in the healthcare sector, Intuitive Surgical serves a significant role in advancing surgical technology and improving patient outcomes. The company collaborates across diverse medical specialties, including urology, gynecology, and general surgery, to expand the applications and accessibility of its robust surgical systems. As an innovator in the medical device industry, Intuitive Surgical has a profound impact not only on surgical methodologies but also on the economic aspects of medical practices by potentially lowering surgical costs. It continues to shape the future of surgery with its commitment to enhancing robotic-assisted techniques.
Official SEC Documents
Advertisement